ARCHIVES

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

This article is from The Cancer Letter archive.

Vol. 29 No. | August 12, 2003

Download PDF Visit The Full Archive

Related Articles

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

Surgical Oncologists Certification Asked By SSO Workshop

December 9, 1983

Judge Declines To Issue Injunction To Stop Amgen’s “Bundling.”

December 1, 2006

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010

In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention

January 17, 1975